Kawamura H, Yoshino N, Murakami K, Kawamura H, Sugiyama I, Sasaki Y, Odagiri T, Sadzuka Y, Muraki Y. The relationship between the chemical structure, physicochemical properties, and mucosal adjuvanticity of sugar-based surfactants. Eur J Pharm Biopharm. 182: 1-11 (2023)
Kagabu M, Yoshino N, Murakami K, Kawamura H, Sasaki Y, Muraki Y, Baba T. Treatment of HPV-related uterine cervical cancer with a third-generation oncolytic herpes simplex virus in combination with an immune checkpoint inhibitor. Int J Mol Sci. 24: 1988 (2023)
Yoshino N, Yokoyama T, Sakai H, Sugiyama I, Odagiri T, Kimura M, Hojo W, Saino T, Muraki Y.:Suitability of polymyxin B as a mucosal adjuvant for intranasal influenza and COVID-19 vaccines. Vaccines (Basel). 11(11): 1727 (2023)
Kagabu M, Kawamura H, Kawamura H, Murakami K, Sasaki Y, Yoshino N, Muraki Y, Baba T.: Efficacy of combination chemotherapy and third-generation oncolytic herpes virus therapy for cervical cancer. International Gynecologic Cancer Society (IGCS) 2023. 2023 Nov. Seoul, Korea.
Yoshino N, Yokoyama T, Sakai H, Sugiyama I, Odagiri T, Kimura M, Hojo W, Saino T, Muraki Y.:Development of influenza and COVID-19 intranasal vaccines containing polymyxin B as a mucosal adjuvant.第70回日本ウイルス学会学術集会.2023年9月.仙台.